Michelle S Cespedes, MD Email Michelle Cespedes
- ASSOCIATE PROFESSOR | Medicine, Infectious Diseases
- Infectious Disease
- Hospital Affiliations
- The Mount Sinai Hospital
- Mount Sinai Morningside and Mount Sinai West
- Mount Sinai Beth Israel
- Mount Sinai Faculty Practice Associates 212-604-6513 212-604-6513
Michelle S. Cespedes, MD, MS, joined the Division of Infectious Disease at the Icahn School of Medicine at Mount Sinai as an Associate Professor of Medicine in 2014. Her research areas of interest are complications and comorbidities of HIV, with an emphasis on HPV, HIV related women's health issues, and HIV prevention in high risk populations. Her basic science interest is genetic factors that predispose HIV infected patients to HPV disease. She is currently the protocol vice-chair of two AIDS Clinical Trial Group (ACTG) studies designed to evaluate the HPV vaccine in HIV infected populations. In 2014, she was named the co-Director of ID Division’s Clinical and Translational Research Center at Mount Sinai and the clinical research site leader of Mt. Sinai West's Samuels Clinic. Nationally, she sits on the ACTG Executive Committee and is the Chair of its Underrepresented Populations Committee.
Please read her article on syphillis in Our Town.
- Anal Warts / Condyloma
- Clostridium Difficile Colitis
- Genital Herpes
- Hepatitis B
- Hepatitis B Vaccine
- Hepatitis C
- Japanese Encephalitis Vaccine
- Low Blood Pressure / Hypotension
- Lyme Disease
- Meningococcal Vaccine
- Pertussis Vaccine
- Pneumocystis Pneumonia
- Polio Vaccine
- Rabies Vaccine
- Rubella Vaccine
- Toxic Shock Syndrome
- Tropical Disease / Parasite / Malaria
- Typhoid Fever
- Typhoid Vaccine
- Yellow Fever Vaccine
MD, Mount Sinai School of Medicine
MS, New York University School of Medicine
Residency, Internal Medicine
Memorial Sloan-Kettering Cancer Center
Residency, Internal Medicine
New York Presbyterian - Weill Cornell Medical Center
Fellowship, Infectious Diseases
Bellevue Hospital Center
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Cespedes during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
- Gilead Sciences, Inc.
- ViiV Healthcare (GlaxoSmithKline / Pfizer Partnership)
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.